1-27370346-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003665.4(FCN3):​c.658+250C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.267 in 484,418 control chromosomes in the GnomAD database, including 19,404 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).

Frequency

Genomes: 𝑓 0.25 ( 5311 hom., cov: 32)
Exomes 𝑓: 0.28 ( 14093 hom. )

Consequence

FCN3
NM_003665.4 intron

Scores

2

Clinical Significance

risk factor no assertion criteria provided O:1

Conservation

PhyloP100: -0.403

Publications

12 publications found
Variant links:
Genes affected
FCN3 (HGNC:3625): (ficolin 3) Ficolins are a group of proteins which consist of a collagen-like domain and a fibrinogen-like domain. In human serum, there are two types of ficolins, both of which have lectin activity. The protein encoded by this gene is a thermolabile beta-2-macroglycoprotein found in all human serum and is a member of the ficolin/opsonin p35 lectin family. The protein, which was initially identified based on its reactivity with sera from patients with systemic lupus erythematosus, has been shown to have a calcium-independent lectin activity. The protein can activate the complement pathway in association with MASPs and sMAP, thereby aiding in host defense through the activation of the lectin pathway. Alternative splicing occurs at this locus and two variants, each encoding a distinct isoform, have been identified. [provided by RefSeq, Jul 2008]
FCN3 Gene-Disease associations (from GenCC):
  • immunodeficiency due to ficolin3 deficiency
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.323 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FCN3NM_003665.4 linkc.658+250C>A intron_variant Intron 7 of 7 ENST00000270879.9 NP_003656.2 O75636-1Q6UY50
FCN3NM_173452.3 linkc.625+250C>A intron_variant Intron 6 of 6 NP_775628.1 O75636-2Q6UXM4Q6UY50

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FCN3ENST00000270879.9 linkc.658+250C>A intron_variant Intron 7 of 7 1 NM_003665.4 ENSP00000270879.4 O75636-1

Frequencies

GnomAD3 genomes
AF:
0.247
AC:
37467
AN:
151972
Hom.:
5310
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.121
Gnomad AMI
AF:
0.362
Gnomad AMR
AF:
0.243
Gnomad ASJ
AF:
0.417
Gnomad EAS
AF:
0.120
Gnomad SAS
AF:
0.166
Gnomad FIN
AF:
0.252
Gnomad MID
AF:
0.342
Gnomad NFE
AF:
0.327
Gnomad OTH
AF:
0.281
GnomAD4 exome
AF:
0.277
AC:
91900
AN:
332328
Hom.:
14093
AF XY:
0.272
AC XY:
47662
AN XY:
175072
show subpopulations
African (AFR)
AF:
0.114
AC:
1159
AN:
10160
American (AMR)
AF:
0.221
AC:
2592
AN:
11730
Ashkenazi Jewish (ASJ)
AF:
0.399
AC:
4165
AN:
10430
East Asian (EAS)
AF:
0.113
AC:
2618
AN:
23130
South Asian (SAS)
AF:
0.165
AC:
5596
AN:
33836
European-Finnish (FIN)
AF:
0.249
AC:
5208
AN:
20892
Middle Eastern (MID)
AF:
0.325
AC:
477
AN:
1466
European-Non Finnish (NFE)
AF:
0.321
AC:
64691
AN:
201356
Other (OTH)
AF:
0.279
AC:
5394
AN:
19328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
3029
6058
9086
12115
15144
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.246
AC:
37472
AN:
152090
Hom.:
5311
Cov.:
32
AF XY:
0.242
AC XY:
18022
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.121
AC:
5016
AN:
41492
American (AMR)
AF:
0.243
AC:
3710
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.417
AC:
1448
AN:
3470
East Asian (EAS)
AF:
0.119
AC:
617
AN:
5178
South Asian (SAS)
AF:
0.167
AC:
804
AN:
4826
European-Finnish (FIN)
AF:
0.252
AC:
2664
AN:
10564
Middle Eastern (MID)
AF:
0.337
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
0.327
AC:
22196
AN:
67964
Other (OTH)
AF:
0.279
AC:
589
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1391
2782
4174
5565
6956
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
404
808
1212
1616
2020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.284
Hom.:
1089
Bravo
AF:
0.244
Asia WGS
AF:
0.135
AC:
469
AN:
3478

ClinVar

Significance: risk factor
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Rheumatic heart disease Other:1
Jan 09, 2019
Biochemistry and Molecular Biology, Faculty of Pharmacy, Al-Azhar University
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.6
DANN
Benign
0.66
PhyloP100
-0.40
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4494157; hg19: chr1-27696837; API